Greenland Mines Ltd SEC filings GRML

Greenland Mines Ltd has 268 filings in SEC EDGAR's recent list, going back to Jan 31, 2022. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change). The company's fiscal year ends on December 31.

Greenland Mines Ltd SEC filings
Form Description Filed Period
EFFECT Filing Nov 3, 2026 —
S-1 Registration statement Oct 26, 2026 —
4 Insider transaction Oct 5, 2026 Oct 1, 2026
8-K Current report
Officer or director change
Oct 2, 2026 Sep 28, 2026
144 Notice of proposed sale Oct 1, 2026 —
424B5 Prospectus supplement Sep 28, 2026 —
8-K Current report
Material agreement
Sep 28, 2026 Sep 23, 2026
424B5 Prospectus supplement Sep 23, 2026 —
8-K Current report
Material agreement
Sep 23, 2026 Sep 21, 2026
424B5 Prospectus supplement Sep 23, 2026 —
8-K Current report
Officer or director change
Sep 11, 2026 Sep 8, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
Sep 4, 2026 Sep 1, 2026
SCHEDULE 13G Ownership over 5% (passive) Sep 2, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Aug 27, 2026 Aug 26, 2026
424B5 Prospectus supplement Aug 27, 2026 —
424B5 Prospectus supplement Aug 25, 2026 —
4 Insider transaction Aug 25, 2026 Aug 25, 2026
8-K Current report
Material agreement
Aug 24, 2026 Aug 24, 2026
424B5 Prospectus supplement Aug 24, 2026 —
10-Q Quarterly report Aug 17, 2026 Jun 30, 2026
10-Q/A Amended quarterly report Aug 14, 2026 Mar 31, 2026
10-K/A Amended annual report Aug 14, 2026 Dec 31, 2025
NT 10-Q Notification of late filing Aug 14, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
Aug 10, 2026 Aug 7, 2026
4 Insider transaction Jul 23, 2026 Jul 22, 2026
8-K Current report
Material agreement, Change to shareholder rights, Other events
Jul 23, 2026 Jul 22, 2026
8-A12B For registration of certain classes Jul 23, 2026 —
8-K Current report
Shareholder vote results
Jul 21, 2026 Jul 16, 2026
8-K Current report
Regulation FD disclosure
Jul 20, 2026 Jul 15, 2026
4 Insider transaction Jul 20, 2026 Jul 20, 2026
4 Insider transaction Jul 17, 2026 Jul 16, 2026
8-K Current report
Auditor change
Jul 8, 2026 Jul 4, 2026
8-K Current report
Auditor change
Jun 29, 2026 Jun 23, 2026
4 Insider transaction Jun 26, 2026 Jun 25, 2026
8-K Current report
Unregistered share sale
Jun 25, 2026 Jun 18, 2026
144 Notice of proposed sale Jun 24, 2026 —
DEF 14A Proxy statement Jun 22, 2026 Jul 16, 2026
424B3 Prospectus Jun 22, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Jun 22, 2026 Jun 15, 2026
8-K Current report
Shareholder vote results
Jun 22, 2026 Jun 18, 2026
8-K Current report
Material agreement
Jun 17, 2026 Jun 15, 2026
PRE 14A Preliminary proxy statement Jun 9, 2026 Jun 9, 2026
DEF 14A Proxy statement May 26, 2026 Jun 18, 2026
8-K Current report
Material agreement
May 21, 2026 May 20, 2026
10-Q Quarterly report May 20, 2026 Mar 31, 2026
8-K/A Amended current report May 19, 2026 Mar 4, 2026
PRE 14A Preliminary proxy statement May 15, 2026 May 15, 2026
NT 10-Q Notification of late filing May 15, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
May 14, 2026 May 13, 2026
8-K Current report
Officer or director change
Apr 22, 2026 Apr 17, 2026
S-8 POS Registration statement Apr 17, 2026 —
10-K Annual report Apr 1, 2026 Dec 31, 2025
NT 10-K Notification of late filing Apr 1, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 23, 2026 Mar 19, 2026
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure, Other events
Mar 16, 2026 Mar 11, 2026
SCHEDULE 13G Ownership over 5% (passive) Mar 13, 2026 —
8-K Current report
Regulation FD disclosure
Mar 12, 2026 Mar 12, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Bylaw or fiscal year change
Mar 10, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
8-K Current report
Regulation FD disclosure
Mar 4, 2026 Mar 4, 2026
8-K Current report
Unregistered share sale
Mar 2, 2026 Feb 27, 2026
424B3 Prospectus Feb 24, 2026 —
8-K Current report
Material agreement
Feb 24, 2026 Feb 19, 2026
8-K Current report
Shareholder vote results
Feb 17, 2026 Feb 17, 2026
DEFR14A Proxy statement Jan 26, 2026 —
DEF 14A Proxy statement Jan 23, 2026 Feb 13, 2026
PRE 14A Preliminary proxy statement Jan 12, 2026 Jan 12, 2026
EFFECT Filing Dec 12, 2025 —
CORRESP Letter to the SEC Dec 10, 2025 —
4 Insider transaction Dec 10, 2025 Dec 10, 2025
4 Insider transaction Dec 10, 2025 Dec 10, 2025
4 Insider transaction Dec 10, 2025 Dec 10, 2025
8-K Current report
Material agreement, Unregistered share sale
Dec 8, 2025 Dec 2, 2025
S-1 Registration statement Dec 5, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
S-8 Employee stock plan registration Nov 6, 2025 —
424B3 Prospectus Sep 30, 2025 —
4 Insider transaction Sep 29, 2025 Sep 25, 2025
8-K Current report
Material agreement
Sep 25, 2025 Sep 19, 2025
8-K Current report
Listing notice
Sep 25, 2025 Sep 19, 2025
4 Insider transaction Aug 26, 2025 Aug 25, 2025
10-Q Quarterly report Aug 18, 2025 Jun 30, 2025
NT 10-Q Notification of late filing Aug 14, 2025 Jun 30, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Aug 12, 2025 Aug 6, 2025
4 Insider transaction Aug 8, 2025 Aug 5, 2025
4 Insider transaction Aug 8, 2025 Aug 7, 2025
4 Insider transaction Aug 8, 2025 Jul 22, 2025
4 Insider transaction Aug 8, 2025 Aug 5, 2025
4 Insider transaction Aug 8, 2025 Aug 5, 2025
4 Insider transaction Aug 8, 2025 Aug 5, 2025
424B5 Prospectus supplement Jul 28, 2025 —
424B3 Prospectus Jul 28, 2025 —
424B3 Prospectus Jul 28, 2025 —
EFFECT Filing Jul 25, 2025 —
CORRESP Letter to the SEC Jul 24, 2025 —
8-K/A Amended current report
Officer or director change
Jul 23, 2025 Aug 26, 2024
CORRESP Letter to the SEC Jul 22, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Jul 22, 2025 Jul 16, 2025
8-K Current report
Listing notice, Regulation FD disclosure
Jul 18, 2025 Jul 14, 2025
UPLOAD Letter from the SEC Jul 17, 2025 —
8-K Current report
Regulation FD disclosure
Jul 10, 2025 Jul 10, 2025
S-3 Shelf registration Jul 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 2, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jul 2, 2025 —
8-K Current report
Regulation FD disclosure
Jun 30, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 16, 2025 Jun 16, 2025
8-K Current report
Material agreement, Unregistered share sale
Jun 13, 2025 Jun 9, 2025
8-K Current report
Material agreement, Unregistered share sale
Jun 11, 2025 Jun 10, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jun 10, 2025 Jun 5, 2025
8-K Current report
Shareholder vote results
Jun 2, 2025 May 28, 2025
PRE 14A Preliminary proxy statement May 28, 2025 May 27, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
DEF 14A Proxy statement May 5, 2025 May 28, 2025
8-K Current report
Listing notice
Apr 21, 2025 Apr 15, 2025
8-K Current report
Other events
Apr 4, 2025 Mar 31, 2025
8-K Current report
Material agreement
Apr 1, 2025 Mar 26, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
PRE 14A Preliminary proxy statement Mar 27, 2025 Mar 26, 2025
8-K Current report
Listing notice
Feb 24, 2025 Feb 14, 2025
424B3 Prospectus Feb 13, 2025 —
EFFECT Filing Feb 10, 2025 —
CORRESP Letter to the SEC Feb 7, 2025 —
UPLOAD Letter from the SEC Feb 6, 2025 —
S-1 Registration statement Jan 30, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Jan 24, 2025 Jan 23, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Dec 10, 2024 Dec 4, 2024
8-K Current report
Officer or director change
Nov 25, 2024 Nov 19, 2024
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
NT 10-Q Notification of late filing Nov 13, 2024 Sep 30, 2024
8-K Current report
Agreement ended
Nov 13, 2024 Nov 8, 2024
8-K Current report
Auditor change
Oct 31, 2024 Oct 26, 2024
8-K Current report
Officer or director change
Oct 31, 2024 Oct 24, 2024
8-K Current report
Listing notice
Oct 21, 2024 Oct 14, 2024
8-K Current report
Other events
Oct 2, 2024 Sep 24, 2024
424B3 Prospectus Oct 1, 2024 —
EFFECT Filing Sep 18, 2024 —
CORRESP Letter to the SEC Sep 17, 2024 —
CORRESP Letter to the SEC Sep 13, 2024 —
S-1/A Amended registration statement Sep 13, 2024 —
UPLOAD Letter from the SEC Sep 12, 2024 —
S-1 Registration statement Sep 5, 2024 —
8-K Current report
Officer or director change
Aug 30, 2024 Aug 25, 2024
8-K Current report
Officer or director change
Aug 22, 2024 Aug 15, 2024
8-K Current report
Listing notice
Aug 22, 2024 Aug 16, 2024
10-Q Quarterly report Aug 19, 2024 Jun 30, 2024
NT 10-Q Notification of late filing Aug 14, 2024 Jun 30, 2024
8-K Current report
Officer or director change
Aug 5, 2024 Jul 30, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
3 Initial insider ownership Jul 1, 2024 Jun 21, 2024
SC 13G Ownership over 5% (passive) Jun 27, 2024 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
Jun 27, 2024 Jun 21, 2024
25-NSE Delisting notice Jun 21, 2024 —
425 Current report Jun 20, 2024 —
8-K Current report
Other events
Jun 20, 2024 Jun 20, 2024
425 Current report Jun 14, 2024 —
8-K/A Amended current report
Material agreement, Unregistered share sale, Other events
Jun 14, 2024 Jun 13, 2024
425 Current report Jun 14, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 14, 2024 Jun 13, 2024
10-Q Quarterly report May 23, 2024 Mar 31, 2024
NT 10-Q Notification of late filing May 15, 2024 Mar 31, 2024
425 Current report May 10, 2024 —
8-K Current report
Material agreement, Other events
May 10, 2024 May 9, 2024
425 Current report Apr 18, 2024 —
8-K Current report
Shareholder vote results, Regulation FD disclosure
Apr 18, 2024 Apr 12, 2024
10-K Annual report Apr 17, 2024 Dec 31, 2023
425 Current report Apr 12, 2024 —
8-K Current report
Other events
Apr 12, 2024 Apr 8, 2024
425 Current report Apr 8, 2024 —
8-K Current report
Other events
Apr 5, 2024 Apr 1, 2024
NT 10-K Notification of late filing Apr 1, 2024 Dec 31, 2023
425 Current report Mar 22, 2024 —
8-K Current report
Other events
Mar 22, 2024 Mar 22, 2024
425 Current report Mar 11, 2024 —
8-K Current report
Other events
Mar 11, 2024 Mar 8, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 22, 2024 —
DEFM14A Proxy statement Feb 20, 2024 —
424B3 Prospectus Feb 16, 2024 —
EFFECT Filing Feb 14, 2024 —
S-4/A Registration statement Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
CORRESP Letter to the SEC Feb 12, 2024 —
S-4/A Registration statement Feb 12, 2024 —
UPLOAD Letter from the SEC Feb 9, 2024 —
S-4/A Registration statement Feb 7, 2024 —
S-4/A Registration statement Feb 1, 2024 —
CORRESP Letter to the SEC Feb 1, 2024 —
UPLOAD Letter from the SEC Jan 16, 2024 —
CORRESP Letter to the SEC Jan 3, 2024 —
S-4/A Registration statement Jan 3, 2024 —
UPLOAD Letter from the SEC Dec 15, 2023 —
CORRESP Letter to the SEC Dec 4, 2023 —
S-4/A Registration statement Dec 4, 2023 —
UPLOAD Letter from the SEC Nov 17, 2023 —
10-Q Quarterly report Nov 17, 2023 Sep 30, 2023
NT 10-Q Notification of late filing Nov 15, 2023 Sep 30, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
GRML (Nasdaq), GRMLW (Nasdaq)
Fiscal year ends
December 31
Headquarters
Omaha, NE
SEC filer status
, Emerging growth company
SEC CIK
1907223
Former names
Klotho Neurosciences, Inc. (until Mar 10, 2026); ANEW Medical, Inc. (until Sep 18, 2024); Redwoods Acquisition Corp. (until Jun 21, 2024)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.